Just remember by them accumulating you are now allowed to pick up a few more shares at discounted prices.
There's always someone that says the same thing about every new bio tech at some point. Look at all the stocks that reached the $20 level on speculation only to drop back down to $1 ranges within a few years. Every stock seems to be the next blockbuster, accumulation target and on and on. A few of them make it but most don't. Hopefully this one will but only time will tell. The one question I have is with all the new insurance coverage. Why haven't analyst come out with new projections of revenue yet? They either can't figure it out yet or it's not as big as some people on this board make it out to be. After all, we still are not back to the original pop and how many more millions have been added for coverage. Makes you think
This will retreat to the SMA quickly before the earnings pop. Remind me again how much they will earn (I mean lose) this quarter? The key analyst question that needs to be asked on the call is how much revenue will each test generate and how many patients will be factored in the numbers. That means they want to calculate new projections??
Since when did you get appointed lead analyst for this stock? Don't think your opinion will carry much weight around here. Let me check the PPS since you posted. Looks like it's down $0.32. Yep, no one's buying your upgrade today, huh?
I haven't disappeared at all. I've just been spending more time on other opportunities recently. I bought back a small position in $5.20s on a recent dip but nothing too big. My $4.50 are still pending and like I said, if I get them great, if not there will be other chances. If we get anymore dips during pre earnings run up, I may just add more but that remains to be seen. The CC questions and answers will be huge going forward, I agree.
I got back in recently but at a higher price than planned. (smaller position than recently sold) Will grab a quick profit thru earnings then we'll see what next quarter will bring. This stock trades up and down a $1 several times over days so it's still a good trade play for now. The buyout if it happens will be awhile yet. This company has so many more tests to do which will only increase its value long term. Why would they want to sell out now?
Everyone wants to know whether or not I'm invested. I find that comforting! I will do my best to make profit and trade wisely going forward.
What you guys are concluding is that every person covered currently under these networks will be a patient for this specific testing and they wont. You will not get 84 million patients just like that. They all don't need cancer cell screening. Hell we don't even know which current patients will now be covered by these new insurers??
So says padrinovuvus the great! Can you predict the weather too?
Maybe get to $1.10 again but not much more than that. The March 31st 13F will tell the tale if Carl has been accumulating since the bond purchase. Be careful, it maybe listed under several new company names with 100K here and there to fly under the radar. That's just like sending money overseas to avoid paying taxes.
Most stocks that will announce good news or good forecasts are sniffed out by insider analyst and they get people to start accumulating for them. There has been none of this which means the 9th will come and go and continued to trade in the same boring $0.01 range every day. Look at TROV, they will announce on the 10th and their 1 month chart shows accumulation and interest in the stock. That's the difference between a loser and a winner.
With the number of short shares, there has to be an average price that would inflict max pain (or mandatory shorty covering). This is the PPS level that the shorts would allow it to run to before trying to hit it hard again. This would be another exit point to consider for those who just want to trade the stock. Always the threat of news so its got to be a calculated risk based on tolerance.
How many current patients does TROV treat and what will be the actual revenue realized per test and how many tests per patient are required per month? That's what the analysts need to address with management in the upcoming CC
Isn't there a maximum loss per short share that forces them to cover at a certain price based on their original short position? Is the loss 5% or 10% before they are forced to cover based on margins? I'm sure that's why they buy and sell all the time to minimize their exposure to one set of short positions. If 200 shares are carrying a loss of 10%, they cover, take the loss and just open another position at the higher number. It's a matter of managing your gains and losses for them I guess. If they buy larger blocks, they could potentially have a larger exposure to covering.
How this stock was left for dead for 6 months based on all the negative nellies that tried to push the idea that AAPL was going to cut production and chip maker stocks would need 6 months to unload inventory. Even though some analysts said the interest was there to use more chips in the iphone 7 they pushed the market down. Gee do you think they wanted to cover cheaply and then establish a long position going in to the next two quarters? I really don't think they are as smart as they are opportunistic. They control the market's moves to the betterment of their gains. That's why you need to have cash on hand and let them discount the stock for you.